To investigate the involvement of neurovasculature in AD pathogenesis (for reviews:[6,31-33]), we created a new AD knock-in mouse model (APP DSL) that develops progressive CAA and amyloid pathology in the absence of transgene overexpression. The gene discussed is APP; the disease is Alzheimer disease.